TrialThe Journal of clinical investigation2015

Anti-thymocyte globulin/G-CSF treatment preserves β cell function in patients with established type 1 diabetes.

Michael J Haller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.